Safety, PD & PK of Multiple Doses of Peginesatide for Anemia in Chronic Kidney Disease Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

139

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
AnemiaChronic Kidney DiseaseChronic Renal Failure
Interventions
DRUG

peginesatide

Trial Locations (13)

Unknown

Research Facility, Bialystok

Research Facility, Gdansk

Research Facility, Katowice

Research Facilities, Krakow

Research Facility, Lodz

Research Facility, Warsaw

Research Facility, Coventry

Research Facility, Croydon

Research Facility, Derby

Research Facility, Leicester

Research Facilities, London

Research Facility, Salford

Research Facility, Swansea

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Affymax

INDUSTRY

NCT00228436 - Safety, PD & PK of Multiple Doses of Peginesatide for Anemia in Chronic Kidney Disease Patients | Biotech Hunter | Biotech Hunter